Journey Medical Corporation (DERM)
USD 4.71
(-2.48%)
USD 4.71
(-2.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 79.18 Million | 73.66 Million | 63.13 Million | 44.53 Million | 34.92 Million | 42.33 Million |
| Cost of Revenue | 26.66 Million | 30.77 Million | 32.08 Million | 14.59 Million | 10.53 Million | 1.17 Million |
| Gross Profit | 52.52 Million | 42.89 Million | 31.05 Million | 29.93 Million | 24.38 Million | 41.16 Million |
| Operating Expenses | 54.59 Million | 70.41 Million | 56.39 Million | 22.08 Million | 19.13 Million | 255.14 Million |
| Selling, General and Administrative Expenses | 43.91 Million | 59.46 Million | 39.83 Million | 22.08 Million | 19.13 Million | 172.58 Million |
| Research and Development Expenses | 7.54 Million | 10.94 Million | 16.55 Million | - | - | 80.54 Million |
| Other Expenses | 3.14 Million | - | 23.35 Million | - | - | 2.01 Million |
| Cost and Expenses | 81.25 Million | 101.18 Million | 88.47 Million | 36.68 Million | 29.66 Million | 256.32 Million |
| Operating Income | -2.07 Million | -27.51 Million | -25.34 Million | 7.85 Million | 5.25 Million | -213.98 Million |
| Interest Expense | 1.69 Million | 2.01 Million | 7.03 Million | 698 Thousand | 255 Thousand | 15.63 Million |
| Income Tax Expense | 221 Thousand | 63 Thousand | 1.63 Million | 1.87 Million | 1.37 Million | -194 Thousand |
| Earnings before Tax | -3.63 Million | -29.56 Million | -42.36 Million | 7.15 Million | 5 Million | -221.73 Million |
| Net Income | -3.85 Million | -29.62 Million | -43.99 Million | 5.28 Million | 3.62 Million | -221.54 Million |
| Earnings Per Share Basic | -0.21 | -1.69 | -2.54 | 0.32 | 0.22 | -5.27 |
| Earnings Per Share Diluted | -0.21 | -1.69 | -2.54 | 0.32 | 0.22 | -5.27 |
| Weighted Average Shares Outstanding | 18.23 Million | 17.53 Million | 17.31 Million | 16.65 Million | 16.65 Million | 42 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.23 Million | 17.53 Million | 17.31 Million | 16.65 Million | 16.65 Million | 42 Million |
| Gross Margin | 0.66 | 0.58 | 0.49 | 0.67 | 0.70 | 0.97 |
| EBIT Margin | 0.02 | -0.37 | -0.40 | 0.21 | 0.19 | -4.85 |
| Profit Margin | -0.05 | -0.40 | -0.70 | 0.12 | 0.10 | -5.23 |
| EBITDA | 1.92 Million | -23.18 Million | -32.76 Million | 9.36 Million | 6.43 Million | -205.54 Million |
| Earnings Before Tax Margin | -0.03 | -0.37 | -0.40 | 0.18 | 0.15 | -5.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 14.85 Million | 13.03 Million | 79.18 Million | 15.25 Million | 34.53 Million | 17.17 Million |
| Cost of Revenue | 6.54 Million | 6.81 Million | 26.66 Million | 6.01 Million | 6.42 Million | 7.76 Million |
| Gross Profit | 8.31 Million | 6.21 Million | 52.52 Million | 9.24 Million | 28.11 Million | 9.4 Million |
| Operating Expenses | 11.24 Million | 16.3 Million | 51.45 Million | 11.34 Million | 10.86 Million | 13.91 Million |
| Selling, General and Administrative Expenses | 10.32 Million | 8.42 Million | - | 9.84 Million | 8.63 Million | 12.14 Million |
| Research and Development Expenses | 913 Thousand | 7.88 Million | - | 1.5 Million | 2.22 Million | 1.77 Million |
| Other Expenses | -814 Thousand | - | -3.76 Million | -815 Thousand | - | 3.14 Million |
| Cost and Expenses | 17.78 Million | 23.12 Million | 78.11 Million | 17.36 Million | 17.29 Million | 21.68 Million |
| Operating Income | -2.92 Million | -10.09 Million | 1.07 Million | -2.1 Million | 17.24 Million | -7.65 Million |
| Interest Expense | 563 Thousand | 548 Thousand | 1.69 Million | 24 Thousand | 268 Thousand | 756 Thousand |
| Income Tax Expense | - | 792.72 Thousand | 221 Thousand | 126 Thousand | 95 Thousand | -2.46 Million |
| Earnings before Tax | -3.36 Million | -10.44 Million | -3.63 Million | -2.01 Million | 16.88 Million | -8.36 Million |
| Net Income | -3.36 Million | -10.44 Million | -3.85 Million | -2.14 Million | 16.78 Million | -8.36 Million |
| Earnings Per Share Basic | -0.17 | -0.53 | - | -0.11 | 0.91 | -0.46 |
| Earnings Per Share Diluted | -0.17 | -0.53 | - | -0.11 | 0.80 | -0.46 |
| Weighted Average Shares Outstanding | 19.99 Million | 19.75 Million | 18.23 Million | 19.32 Million | 18.41 Million | 18 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.99 Million | 19.75 Million | 18.23 Million | 19.32 Million | 21.03 Million | 18 Million |
| Gross Margin | 0.56 | 0.48 | 0.66 | 0.61 | 0.81 | 0.55 |
| EBIT Margin | -0.14 | -0.71 | - | -0.08 | 0.50 | -0.26 |
| Profit Margin | -0.23 | -0.80 | -0.05 | -0.14 | 0.49 | -0.49 |
| EBITDA | -2.08 Million | -9.25 Million | - | -1.26 Million | 17.25 Million | -4.43 Million |
| Earnings Before Tax Margin | -0.20 | -0.77 | 0.01 | -0.14 | 0.50 | -0.45 |
OEM-B
EWRK
7619
7199
NATPLY
SUEZF